Suppliers and packagers for ZEPBOUND (AUTOINJECTOR)

ZEPBOUND (AUTOINJECTOR)

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant	Tradename	Generic Name	Dosage	NDA	NDA/ANDA	Supplier	Package Code	Package	Marketing Start
Eli Lilly And Co	ZEPBOUND (AUTOINJECTOR)	tirzepatide	SOLUTION;SUBCUTANEOUS	217806	NDA	Eli Lilly and Company	0002-0152-01	1 VIAL, SINGLE-DOSE in 1 CARTON (0002-0152-01) / .5 mL in 1 VIAL, SINGLE-DOSE	2024-03-28
Eli Lilly And Co	ZEPBOUND (AUTOINJECTOR)	tirzepatide	SOLUTION;SUBCUTANEOUS	217806	NDA	Eli Lilly and Company	0002-0152-04	4 VIAL, SINGLE-DOSE in 1 CARTON (0002-0152-04) / .5 mL in 1 VIAL, SINGLE-DOSE	2024-03-28
Eli Lilly And Co	ZEPBOUND (AUTOINJECTOR)	tirzepatide	SOLUTION;SUBCUTANEOUS	217806	NDA	Eli Lilly and Company	0002-0152-61	4 VIAL, SINGLE-DOSE in 1 CARTON (0002-0152-61) / .5 mL in 1 VIAL, SINGLE-DOSE	2024-03-28
Eli Lilly And Co	ZEPBOUND (AUTOINJECTOR)	tirzepatide	SOLUTION;SUBCUTANEOUS	217806	NDA	Eli Lilly and Company	0002-0243-01	1 VIAL, SINGLE-DOSE in 1 CARTON (0002-0243-01) / .5 mL in 1 VIAL, SINGLE-DOSE	2024-03-28
Eli Lilly And Co	ZEPBOUND (AUTOINJECTOR)	tirzepatide	SOLUTION;SUBCUTANEOUS	217806	NDA	Eli Lilly and Company	0002-0243-04	4 VIAL, SINGLE-DOSE in 1 CARTON (0002-0243-04) / .5 mL in 1 VIAL, SINGLE-DOSE	2024-03-28
Eli Lilly And Co	ZEPBOUND (AUTOINJECTOR)	tirzepatide	SOLUTION;SUBCUTANEOUS	217806	NDA	Eli Lilly and Company	0002-1214-01	1 VIAL, SINGLE-DOSE in 1 CARTON (0002-1214-01) / .5 mL in 1 VIAL, SINGLE-DOSE	2024-03-28
Eli Lilly And Co	ZEPBOUND (AUTOINJECTOR)	tirzepatide	SOLUTION;SUBCUTANEOUS	217806	NDA	Eli Lilly and Company	0002-1214-04	4 VIAL, SINGLE-DOSE in 1 CARTON (0002-1214-04) / .5 mL in 1 VIAL, SINGLE-DOSE	2024-03-28

Suppliers and packagers for ZEPBOUND (AUTOINJECTOR)

Last updated: April 26, 2026

Who Supplies the Zepbound (Autoinjector) Value Chain?

Zepbound (tirzepatide) comes in a prefilled, single-use autoinjector format. No supplier roster can be produced from the information available in this request. A defensible supplier list for the autoinjector requires at least one of the following: (i) the manufacturer-to-component BOM disclosures, (ii) official device labeling identifying the primary device manufacturer, or (iii) regulatory filings or procurement records that name fill-finish and device supply partners. Without those inputs, any “supplier” attribution would be speculative and not fit for high-stakes R&D or investment decisions.

What supplier types exist for an autoinjector drug product?

A complete supplier map for a prefilled autoinjector drug product typically spans these categories:

Supply layer	What it covers	Typical naming sources
Device manufacturer	The pen body, needle system, safety mechanism, springs, and injector electronics (if present)	Package insert, labeling, regulatory device section
Primary container and closure	Prefilled syringe/pen reservoir, stoppers, seals	Product labeling, regulatory chemistry/manufacturing sections
Drug fill-finish	Aseptic filling, lyophilized reconstitution (if any), labeling, and final assembly	NDA/BLA manufacturing tables, inspection reports
Subcomponent suppliers	Needle, seals, elastomers, springs, sensors	Vendor qualification packages and change-control documents
Contract manufacturer / packager	Kitting, outer packaging, serialization	CMC supply chain documentation

What is required to list specific suppliers for Zepbound autoinjectors

To name suppliers, the underlying document set must explicitly identify at least one of:

• the autoinjector device manufacturer
• the fill-finish site(s)
• the final assembly or packaging site(s)

In the absence of such naming, a supplier list cannot be generated without introducing unsupported claims.

---

Key Takeaways

• A supplier roster for Zepbound (autoinjector) cannot be established from the request alone.
• Autoinjector supply chains require explicit labeling or regulatory manufacturing disclosures to name device and fill-finish partners.
• Any attempt to list “suppliers” without those named sources would not be suitable for R&D or investment use.

---

FAQs

1) Are Zepbound autoinjectors supplied by the same company that makes tirzepatide API?
Not determinable from the provided input; autoinjector drug products commonly split API, fill-finish, and device supply across different contractors.

2) Does Zepbound use a proprietary autoinjector platform with identifiable hardware suppliers?
Yes in concept, but the specific supplier names must be taken from labeling or regulatory CMC/device documentation.

3) Who performs the aseptic fill-finish for prefilled tirzepatide products?
That depends on the licensed fill-finish sites listed in regulatory filings for the product and strength.

4) Can retailers or pharmacies indicate the autoinjector manufacturer?
Sometimes through labeling, but pharmacy-level packaging does not reliably expose device manufacturer names.

5) Can public press releases replace regulatory disclosures for supplier identification?
Only when they explicitly name the device or manufacturing partners; otherwise they are insufficient for a defensible supplier list.

---

References (APA)

No sources were provided in the prompt, and no supplier-identifying documents were included.